Trademark: 97403419
Word
ASTARABINE
Status
Pending
Status Code
731
Status Date
Wednesday, May 29, 2024
Serial Number
97403419
Mark Type
4
Filing Date
Tuesday, May 10, 2022
Published for Opposition
Tuesday, April 4, 2023
Trademark Owner History
BioSight Ltd. - Owner At Publication
Classifications
5 Pharmaceutical preparations containing arabinofuranosyl derivatives for the treatment of cancer
Trademark Events
May 13, 2022
New Application Entered
May 16, 2022
New Application Office Supplied Data Entered
Feb 27, 2023
Assigned To Examiner
Mar 2, 2023
Examiners Amendment -Written
Mar 2, 2023
Examiners Amendment E-Mailed
Mar 2, 2023
Notification Of Examiners Amendment E-Mailed
Mar 2, 2023
Examiner's Amendment Entered
Mar 2, 2023
Approved For Pub - Principal Register
Mar 15, 2023
Notification Of Notice Of Publication E-Mailed
Apr 4, 2023
Published For Opposition
Apr 4, 2023
Official Gazette Publication Confirmation E-Mailed
May 30, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 29, 2023
Sou Teas Extension Received
Nov 29, 2023
Sou Extension 1 Filed
Nov 29, 2023
Sou Extension 1 Granted
Nov 30, 2023
Notice Of Approval Of Extension Request E-Mailed
May 29, 2024
Sou Teas Extension Received
May 29, 2024
Sou Extension 2 Granted
May 29, 2024
Sou Extension 2 Filed
May 30, 2024
Notice Of Approval Of Extension Request E-Mailed
ATF
PRIMAL EATS
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov